[Continuous subcutaneous morphine--treatment of pain in patients with terminal cancer].Ugeskr Laeger. 1990 Jun 11; 152(24):1722-3.UL
Abstract
Nine patients with terminal cancer were treated for pain with continuous subcutaneous injection of morphine via a portable battery-driven injection pump. Treatment was instituted on account of failure of other forms of treatment with oral or epidural morphine derivatives or on account of severe nausea and vomiting which necessitated parenteral administration. Treatment proved reasonably effective and no side effects of significance occurred. Two of the patients could be treated in their homes. The method is thus considered as suitable for treatment of pain in patients with terminal cancer.
MeSH
Pub Type(s)
English Abstract
Journal Article
Language
dan
PubMed ID
1694330
Citation
Nielsen, F B., et al. "[Continuous Subcutaneous Morphine--treatment of Pain in Patients With Terminal Cancer]." Ugeskrift for Laeger, vol. 152, no. 24, 1990, pp. 1722-3.
Nielsen FB, Clemensen SE, Olesen AS, et al. [Continuous subcutaneous morphine--treatment of pain in patients with terminal cancer]. Ugeskr Laeger. 1990;152(24):1722-3.
Nielsen, F. B., Clemensen, S. E., Olesen, A. S., & Hole, P. (1990). [Continuous subcutaneous morphine--treatment of pain in patients with terminal cancer]. Ugeskrift for Laeger, 152(24), 1722-3.
Nielsen FB, et al. [Continuous Subcutaneous Morphine--treatment of Pain in Patients With Terminal Cancer]. Ugeskr Laeger. 1990 Jun 11;152(24):1722-3. PubMed PMID: 1694330.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Continuous subcutaneous morphine--treatment of pain in patients with terminal cancer].
AU - Nielsen,F B,
AU - Clemensen,S E,
AU - Olesen,A S,
AU - Hole,P,
PY - 1990/6/11/pubmed
PY - 1990/6/11/medline
PY - 1990/6/11/entrez
SP - 1722
EP - 3
JF - Ugeskrift for laeger
JO - Ugeskr Laeger
VL - 152
IS - 24
N2 - Nine patients with terminal cancer were treated for pain with continuous subcutaneous injection of morphine via a portable battery-driven injection pump. Treatment was instituted on account of failure of other forms of treatment with oral or epidural morphine derivatives or on account of severe nausea and vomiting which necessitated parenteral administration. Treatment proved reasonably effective and no side effects of significance occurred. Two of the patients could be treated in their homes. The method is thus considered as suitable for treatment of pain in patients with terminal cancer.
SN - 0041-5782
UR - https://www.unboundmedicine.com/medline/citation/1694330/[Continuous_subcutaneous_morphine__treatment_of_pain_in_patients_with_terminal_cancer]_
L2 - https://medlineplus.gov/palliativecare.html
DB - PRIME
DP - Unbound Medicine
ER -